PSNL

14.3702.38%
RC

Richard Chen

President & Chief Medical Officer

Dr. Richard Chen, M.D. & M.S., has been the President at Personalis, Inc. since March 2026. Dr. Chen is a General Partner at 1confirmation. He serves as the Chief Medical Officer at Personalis, Inc. since July 2021 and also served as Executive Vice President of R&D since March 02, 2023 until March 2026 and also served as Senior Vice President of R&D since July 2021 until 2023 and served as its Chief Scientific Officer since November 23, 2011 until September 2021. Dr. Chen Co-Founded Qiagen Redwood City, Inc. (formerly, Ingenuity Systems, Inc.) in 1998 and served as its Vice President of Knowledge Engineering and Bioinformatics and Vice President of Product Strategy. His areas of expertise include knowledge representation, ontologies, data mining, bioinformatics and the philosophy of science. He helped develop novel representations for scientific knowledge that supported sophisticated, intelligent visualization and computation over that knowledge in his work at Stanford University School of Medicine since September 2011. These methods were applied to building three-dimensional models of the 30S ribosomal subunit and more generally to diagnosis of data/model conflicts encountered in scientific computation. He served as a Director of Qiagen Redwood City, Inc. Dr. Chen’s scientific leadership, Personalis developed and accelerated adoption of the NeXT Personal platform, which set a new industry benchmark for ultrasensitive MRD testing, detecting cancer at levels far below those previously achievable. As President, Dr. Chen oversees the integration of the company’s R&D capabilities, biopharma services, reimbursement, quality systems and medical affairs to capitalize on the technical excellence of the Personalis platform and accelerate revenue growth. His deep expertise in genomic medicine and machine learning and his track record of moving innovative R&D projects into high-growth clinical products, make him the ideal leader to help drive this next phase of the company's evolution. Dr. Chen holds a BS in Computer Science from Stanford University, an M.S. in biomedical Informatics from Stanford University School of Medicine and an M.D. from Stanford University School of Medicine.

Positions